These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9336325)

  • 21. Discriminative stimulus effects of 5.6 mg/kg pregnanolone in DBA/2J and C57BL/6J inbred mice.
    Shannon EE; Purdy RH; Grant KA
    Alcohol; 2005 Aug; 37(1):35-45. PubMed ID: 16472717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice.
    Hanania T; Zahniser NR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):431-40. PubMed ID: 11981117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds.
    Baker LE; Riddle EE; Saunders RB; Appel JB
    Behav Pharmacol; 1993 Feb; 4(1):69-79. PubMed ID: 11224173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine and N-methyl-D-aspartate have positive modulatory actions on their respective discriminative stimulus properties in C57BL/6 mice.
    Vunck SA; Wiebelhaus JM; Arnt J; Porter JH
    Eur J Pharmacol; 2011 Jan; 650(2-3):579-85. PubMed ID: 20969851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
    Marona-Lewicka D; Nichols DE
    Behav Pharmacol; 2009 Feb; 20(1):114-8. PubMed ID: 19179855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
    Grant KA; Colombo G; Grant J; Rogawski MA
    Neuropharmacology; 1996; 35(12):1709-19. PubMed ID: 9076750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
    Koek W; Colpaert FC; Vignon J
    J Pharmacol Exp Ther; 1993 Feb; 264(2):746-56. PubMed ID: 8437123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
    Zakharova ES; Danysz W; Bespalov AY
    Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.
    Levin ED; Petro A; Caldwell DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
    Allen RM; Carelli RM; Dykstra LA; Suchey TL; Everett CV
    J Pharmacol Exp Ther; 2005 Oct; 315(1):449-57. PubMed ID: 16024734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists.
    Willetts J; Rice A; Balster RL
    Behav Pharmacol; 1990; 1(5):453-458. PubMed ID: 11175430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centrally administered N-methyl-d-aspartate evokes the adrenal secretion of noradrenaline and adrenaline by brain thromboxane A2-mediated mechanisms in rats.
    Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Yorimitsu M; Yokotani K
    Eur J Pharmacol; 2008 May; 586(1-3):145-50. PubMed ID: 18374330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats.
    Calcina F; Barocelli E; Bertoni S; Furukawa O; Kaunitz J; Impicciatore M; Sternini C
    Neuroscience; 2005; 134(1):39-49. PubMed ID: 15939544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acidA receptor blockade in the basolateral amygdala of rats.
    Sajdyk TJ; Shekhar A
    J Pharmacol Exp Ther; 1997 Nov; 283(2):969-77. PubMed ID: 9411030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethanol-like discriminative stimulus effects of non-competitive n-methyl-d-aspartate antagonists.
    Grant KA; Knisely JS; Tabakoff B; Barrett JE; Balster RL
    Behav Pharmacol; 1991 Apr; 2(2):87-95. PubMed ID: 11224052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats.
    Zajaczkowski W; Moryl E; Papp M
    Pharmacol Biochem Behav; 1996 Sep; 55(1):163-8. PubMed ID: 8870053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats.
    Bespalov AY; Beardsley PM; Balster RL
    Pharmacol Biochem Behav; 1998 Jun; 60(2):507-17. PubMed ID: 9632234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.
    Geter-Douglass B; Witkin JM
    Psychopharmacology (Berl); 1997 Sep; 133(1):43-50. PubMed ID: 9335079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
    Witkin JM; Brave S; French D; Geter-Douglass B
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.